Director, Medical Information

Company Overview: Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. Position Overview: Beam is seeking a driven and scientifically rigorous Director of Medical Information to build and lead the Medical Information (MI) function. This is a hands-on leadership role well-suited to a motivated individual contributor and emerging leader who is passionate about establishing strong operational foundations and delivering high-quality scientific content in the rare disease space. The Director of Medical Information will design and implement core MI capabilities — including inquiry management systems, standard response documents, and medical review workflows — positioning the organization for its first commercial launch and scaling for future clinical programs. The Director of Medical Information will also play an active role in the company's Medical Affairs AI initiatives, contributing scientific and operational expertise to the responsible deployment of AI-enabled tools for content generation and knowledge management. Responsibilities: Establish the Medical Information department from the ground up, including defining the operating model, staffing plan, technology infrastructure, and standard operating procedures (SOPs). Develop and maintain the MI quality framework to ensure all scientific content meets regulatory, compliance, and scientific integrity standards. Serve as the internal subject matter expert on medical information best practices, regulatory expectations (FDA, EMA), and industry benchmarks for rare disease and advanced therapies. Build and oversee the medical review process for promotional and non-promotional materials, ensuring scientific accuracy and alignment with label and clinical data. Partner in the establishment of a Medical Review Committee (MRC) / Promotional Review Committee (PRC), collaborating closely with Regulatory Affairs, Legal, and Commercial teams. Create and maintain a comprehensive library of standard response documents (SRDs), custom responses, and medical FAQs covering the company's cell and gene therapy pipeline across rare disease indications. Author and review medical information letters, disease education materials, clinical summaries, and scientific dossiers for internal and external use. Ensure all MI content reflects the most current evidence base, including clinical trial data, real-world evidence, and peer-reviewed literature. Partner with Medical Science Liaisons (MSLs), Clinical Development, and Commercial teams to develop scientifically rigorous training materials, slide decks, and internal reference tools. Lead the development of pipeline and disease area resources that enable cross-functional teams to communicate accurately about the science of cell and gene therapies. Contribute to publication planning and medical education initiatives, supporting the Medical Affairs strategy for pre-launch and post-launch activities. Collaborate with Patient Advocacy and Medical Communications to ensure content is accessible, accurate, and patient-centered. Contribute as a Medical Affairs subject matter expert to the company's AI strategy, partnering with Data Science, IT, and Medical Affairs lead